Natasha Struewing
Women's Health · Greensburg, INNPI 1346556164
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 317 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 37 manufacturers reported payments, led by AbbVie at 36.1% of the total. Among women's health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 317 payments — averaging $14.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$337
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$217
- Lilly USA, LLC$206
- Amgen$189
- Bayer$177
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,583100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$4,583 in reported general payments places this provider in the 95th percentile of 142 women's health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 17 | $25,094 |
| FarxigaDapagliflozin Propanediol | 14 | $18,253 |
| LinzessLinaclotide | 14 | $17,472 |
| EliquisApixaban | 11 | $12,359 |
| QuliptaAtogepant | 12 | $11,614 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $6,948 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $2,063 |
| Estradiol | 33 | $1,561 |
| Omeprazole | 100 | $1,499 |
| Atorvastatin Calcium | 158 | $1,095 |
| Gabapentin | 83 | $1,093 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 72 | $950 |
| SynthroidLevothyroxine Sodium | 11 | $895 |
| Levothyroxine Sodium | 84 | $763 |
| Pantoprazole Sodium | 39 | $752 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Qulipta, Synthroid | $1,652 | $29,98137 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $79 | $25,20126 claims |
| Boehringer IngelheimJardiance | $122 | $25,09417 claims |
| PfizerEliquis | $144 | $12,35911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 142 women's health providers in Indiana.
Other women's health in Greensburg
- Cara RaunickIndianapolis$73K
- Debra TaylorGreenwood$33K
- Elizabeth FourmanNotre Dame$15K
- Amanda NakashianDyer$8K
- Courtney CortezIndianapolis$5K
- Rebecca PapamihalakisMunster$4K
- Kesha KellyIndianapolis$4K
- Amanda PhelpsEvansville$4K
- Taylor JohnsonNoblesville$4K
- Terri KyleAnderson$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.